{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:15:02Z","timestamp":1778084102279,"version":"3.51.4"},"reference-count":57,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2018.4290","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T09:33:55Z","timestamp":1519810435000},"source":"Crossref","is-referenced-by-count":2,"title":["CRISPR\/Cas9-mediated ASXL1 mutations in U937 cells disrupt myeloid differentiation"],"prefix":"10.3892","author":[{"given":"Zhi-Jie","family":"Wu","sequence":"first","affiliation":[{"name":"Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Banaszak","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Gutierrez-Rodrigues","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyvan","family":"Keyvanfar","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou-Guo","family":"Gao","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Quinones Raffo","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Kajigaya","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal","family":"Young","sequence":"additional","affiliation":[{"name":"Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1202, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,2,28]]},"reference":[{"key":"key20200713184614_b1-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/1471-2407-10-401","article-title":"Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias","volume":"10","author":"Rocquain","year":"2010","journal-title":"BMC Cancer"},{"key":"key20200713184614_b2-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/j.1365-2141.2009.07697.x","article-title":"Mutations of polycomb-associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia","volume":"145","author":"Gelsi-Boyer","year":"2009","journal-title":"Br J Haematol"},{"key":"key20200713184614_b3-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/leu.2010.20","article-title":"Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia","volume":"24","author":"Boultwood","year":"2010","journal-title":"Leukemia"},{"key":"key20200713184614_b4-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1200\/JCO.2010.33.4938","article-title":"Prognostic significance of ASXL1 mutations in patients with myelodysplastic syndromes","volume":"29","author":"Thol","year":"2011","journal-title":"J Clin Oncol"},{"key":"key20200713184614_b5-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1365-2141.2010.08381.x","article-title":"ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia","volume":"151","author":"Gelsi-Boyer","year":"2010","journal-title":"Br J Haematol"},{"key":"key20200713184614_b6-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/leu.2014.301","article-title":"SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS","volume":"29","author":"Inoue","year":"2015","journal-title":"Leukemia"},{"key":"key20200713184614_b7-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/leu.2012.262","article-title":"ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome","volume":"27","author":"Schnittger","year":"2013","journal-title":"Leukemia"},{"key":"key20200713184614_b8-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1080\/10428194.2016.1179296","article-title":"ASXL1 mutations are frequent in de novo AML with trisomy 8 and confer an unfavorable prognosis","volume":"58","author":"Zong","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"key20200713184614_b9-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.leukres.2014.11.026","article-title":"AML with gain of chromosome 8 as the sole chromosomal abnormality (+8 sole) is associated with a specific molecular mutation pattern including ASXL1 mutations in 46.8% of the patients","volume":"39","author":"Alpermann","year":"2015","journal-title":"Leuk Res"},{"key":"key20200713184614_b10-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1056\/NEJMoa1414799","article-title":"Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia","volume":"373","author":"Yoshizato","year":"2015","journal-title":"N Engl J Med"},{"key":"key20200713184614_b11-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ydbio.2009.10.004","article-title":"Additional sex combs-like 1 belongs to the enhancer of trithorax and polycomb group and genetically interacts with Cbx2 in mice","volume":"337","author":"Fisher","year":"2010","journal-title":"Dev Biol"},{"key":"key20200713184614_b12-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1074\/jbc.M110.177816","article-title":"Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles in adipogenesis via reciprocal regulation of peroxisome proliferator-activated receptor {gamma}","volume":"286","author":"Park","year":"2011","journal-title":"J Biol Chem"},{"key":"key20200713184614_b13-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"17588","DOI":"10.1074\/jbc.M512616200","article-title":"Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor","volume":"281","author":"Cho","year":"2006","journal-title":"J Biol Chem"},{"key":"key20200713184614_b14-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/bjc.2013.281","article-title":"Functional and cancer genomics of ASXL family members","volume":"109","author":"Katoh","year":"2013","journal-title":"Br J Cancer"},{"key":"key20200713184614_b15-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nature08966","article-title":"Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB","volume":"465","author":"Scheuermann","year":"2010","journal-title":"Nature"},{"key":"key20200713184614_b16-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1084\/jem.20131141","article-title":"Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo","volume":"210","author":"Abdel-Wahab","year":"2013","journal-title":"J Exp Med"},{"key":"key20200713184614_b17-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1172\/JCI70739","article-title":"Myelodysplastic syndromes are induced by histone methylation-altering ASXL1 mutations","volume":"123","author":"Inoue","year":"2013","journal-title":"J Clin Invest"},{"key":"key20200713184614_b18-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1182\/blood-2013-05-500272","article-title":"Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice","volume":"123","author":"Wang","year":"2014","journal-title":"Blood"},{"key":"key20200713184614_b19-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1038\/leu.2009.141","article-title":"Mutations of ASXL1 gene in myeloproliferative neoplasms","volume":"23","author":"Carbuccia","year":"2009","journal-title":"Leukemia"},{"key":"key20200713184614_b20-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/leu.2009.218","article-title":"Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias","volume":"24","author":"Carbuccia","year":"2010","journal-title":"Leukemia"},{"key":"key20200713184614_b21-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ccr.2012.06.032","article-title":"ASXL1 mutations promote myeloid transformation through loss of PRC2-mediated gene repression","volume":"22","author":"Abdel-Wahab","year":"2012","journal-title":"Cancer Cell"},{"key":"key20200713184614_b22-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.exphem.2016.08.011","article-title":"Loss of ASXL1 triggers an apoptotic response in human hematopoietic stem and progenitor cells","volume":"44","author":"Hilgendorf","year":"2016","journal-title":"Exp Hematol"},{"key":"key20200713184614_b23-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bcmd.2017.12.002","article-title":"Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR\/Cas9 gene editing","volume":"69","author":"Banaszak","year":"2018","journal-title":"Blood Cells Mol Dis"},{"key":"key20200713184614_b24-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: An efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"key20200713184614_b25-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nprot.2012.016","article-title":"Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks","volume":"7","author":"Trapnell","year":"2012","journal-title":"Nat Protoc"},{"key":"key20200713184614_b26-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: A Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"key20200713184614_b27-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/bioinformatics\/btl140","article-title":"Improved scoring of functional groups from gene expression data by decorrelating GO graph structure","volume":"22","author":"Alexa","year":"2006","journal-title":"Bioinfomatics"},{"key":"key20200713184614_b28-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nmeth.1528","article-title":"Analysis and design of RNA sequencing experiments for identifying isoform regulation","volume":"7","author":"Katz","year":"2010","journal-title":"Nat Methods"},{"key":"key20200713184614_b29-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) methods","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713184614_b30-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.mrrev.2014.05.001","article-title":"Nonsense-mediated decay in genetic disease: Friend or foe","volume":"762","author":"Miller","year":"2014","journal-title":"Mutat Res Rev Mutat Res"},{"key":"key20200713184614_b31-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/bjh.12217","article-title":"Silencing of ASXL1 impairs the granulomonocytic lineage potential of human CD34+ progenitor cells","volume":"160","author":"Davies","year":"2013","journal-title":"Br J Haematol"},{"key":"key20200713184614_b32-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"44061","DOI":"10.18632\/oncotarget.6392","article-title":"ASXL1 mutation correction by CRISPR\/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts","volume":"6","author":"Valletta","year":"2015","journal-title":"Oncotarget"},{"key":"key20200713184614_b33-ijo-52-04-1209","first-page":"9","article-title":"Distinct activities of interferon-gamma, lymphokine and cytokine differentiation-inducing factors acting on the human monoblastic leukemia cell line U937","volume":"45","author":"Harris","year":"1985","journal-title":"Cancer Res"},{"key":"key20200713184614_b34-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/jlb.63.4.405","article-title":"Transcription factors that regulate monocyte\/macrophage differentiation","volume":"63","author":"Valledor","year":"1988","journal-title":"J Leukoc Biol"},{"key":"key20200713184614_b35-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/00062752-200107000-00001","article-title":"Hematologic malignancies","volume":"8","author":"Gilliland","year":"2001","journal-title":"Curr Opin Hematol"},{"key":"key20200713184614_b36-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/ni.2921","article-title":"Neutrophils at work","volume":"15","author":"Nauseef","year":"2014","journal-title":"Nat Immunol"},{"key":"key20200713184614_b37-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature08313","article-title":"Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation","volume":"461","author":"Owusu-Ansah","year":"2009","journal-title":"Nature"},{"key":"key20200713184614_b38-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cell.2007.01.003","article-title":"FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress","volume":"128","author":"Tothova","year":"2007","journal-title":"Cell"},{"key":"key20200713184614_b39-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0161-5890(02)00004-4","article-title":"TREM-1, MDL-1, and DAP12 expression is associated with a mature stage of myeloid development","volume":"38","author":"Gingras","year":"2002","journal-title":"Mol Immunol"},{"key":"key20200713184614_b40-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.molimm.2010.10.016","article-title":"CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation","volume":"48","author":"Batliner","year":"2011","journal-title":"Mol Immunol"},{"key":"key20200713184614_b41-ijo-52-04-1209","first-page":"911","article-title":"Characterization of cytarabine-resistant leukemic cell lines established from five different blood cell lineages using gene expression and proteomic analyses","volume":"38","author":"Negoro","year":"2011","journal-title":"Int J Oncol"},{"key":"key20200713184614_b42-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"e60027","DOI":"10.1371\/journal.pone.0060027","article-title":"Investigation of tumor suppressing function of CACNA2D3 in esophageal squamous cell carcinoma","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"key20200713184614_b43-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/bjc.2012.231","article-title":"Methylation of the calcium channel regulatory subunit \u03b12\u03b4-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas","volume":"107","author":"Palmieri","year":"2012","journal-title":"Br J Cancer"},{"key":"key20200713184614_b44-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1053\/j.gastro.2008.05.041","article-title":"Methylation of the calcium channel-related gene, CACNA2D3, is frequent and a poor prognostic factor in gastric cancer","volume":"135","author":"Wanajo","year":"2008","journal-title":"Gastroenterology"},{"key":"key20200713184614_b45-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1111\/j.1755-148X.2011.00929.x","article-title":"CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma","volume":"24","author":"Price","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"key20200713184614_b46-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1038\/onc.2012.204","article-title":"AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia","volume":"32","author":"Jin","year":"2013","journal-title":"Oncogene"},{"key":"key20200713184614_b47-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"17409","DOI":"10.1038\/srep17409","article-title":"Transcriptome analysis of human OXR1 depleted cells reveals its role in regulating the p53 signaling pathway","volume":"5","author":"Yang","year":"2015","journal-title":"Sci Rep"},{"key":"key20200713184614_b48-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1182\/blood-2009-07-230698","article-title":"Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia","volume":"115","author":"Fisher","year":"2010","journal-title":"Blood"},{"key":"key20200713184614_b49-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1182\/blood-2011-02-292102","article-title":"New mutations and pathogenesis of myeloproliferative neoplasms","volume":"118","author":"Vainchenker","year":"2011","journal-title":"Blood"},{"key":"key20200713184614_b50-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.exphem.2015.11.011","article-title":"Truncation mutants of ASXL1 observed in myeloid malignancies are expressed at detectable protein levels","volume":"44","author":"Inoue","year":"2016","journal-title":"Exp Hematol"},{"key":"key20200713184614_b51-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.1038\/ncomms8307","article-title":"Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex","volume":"6","author":"Balasubramani","year":"2015","journal-title":"Nat Commun"},{"key":"key20200713184614_b52-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1182\/blood-2014-04-522136","article-title":"Recent developments in myelodysplastic syndromes","volume":"124","author":"Bejar","year":"2014","journal-title":"Blood"},{"key":"key20200713184614_b53-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1756-8722-5-12","article-title":"Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases","volume":"5","author":"Gelsi-Boyer","year":"2012","journal-title":"J Hematol Oncol"},{"key":"key20200713184614_b54-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1182\/blood-2011-12-400994","article-title":"Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes","volume":"119","author":"Damm","year":"2012","journal-title":"Blood"},{"key":"key20200713184614_b55-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1182\/blood-2012-05-430876","article-title":"SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes","volume":"120","author":"Visconte","year":"2012","journal-title":"Blood"},{"key":"key20200713184614_b56-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/leu.2014.331","article-title":"Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells","volume":"29","author":"Dolatshad","year":"2015","journal-title":"Leukemia"},{"key":"key20200713184614_b57-ijo-52-04-1209","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1101\/gr.181016.114","article-title":"U2AF1 mutations alter splice site recognition in hematological malignancies","volume":"25","author":"Ilagan","year":"2015","journal-title":"Genome Res"}],"container-title":["International Journal of Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T18:57:10Z","timestamp":1594666630000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2018.4290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,28]]},"references-count":57,"URL":"https:\/\/doi.org\/10.3892\/ijo.2018.4290","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,28]]}}}